Neonatal Intensive Care Respiratory Devices Market By Device Type (Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Pressure Devices, Apnea Monitors), By End User (NICU Hospitals, Specialty Clinics, Nursing Homes) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027
"Neonatal intensive care respiratory devices market to exhibit productive growth during the forecast period"
The global neonatal intensive care respiratory devices market is growing effectively, was valued at US$ 1,396.5 Mn in 2018 and expected to reach US$ 2,134.5 Mn by 2027. Globally increasing breathing disorders in the newborn babies, along with prevalence of respiratory disorders has significantly increased the revenue on a global scale. Acquisitions along with new respiratory equipment and device launches in the neonatal care industry are driving the overall growth in the emerging nations on a global scale.
"Continuous positive airway pressure devices segment is expected to register higher growth by the end of 2027"
New technology evolution in the design of neonatal intensive care respiratory devices, high prevalence for respiratory disorders and upsurge in incidence of preterm births and equivalent efforts to improve survival rates are probable to fuel the overall demand of respiratory devices. The ventilators in the device type segment generated maximum revenue share globally due to its need in hospitals and clinics along with new technology expansion for advanced ventilators globally. Furthermore, growth in healthier reimbursement simulations, and demand for low cost inhalers and nebulizers in neonatal intensive care respiratory devices technology are factors driving the growth on global scale.
"Increasing admissions due to respiratory disorders in the hospital segment to witness a significant CAGR"
Increasing cardiovascular, and other respiratory diseases in infants are notable variables expected for the growth of the global neonatal intensive care respiratory devices market. According to FDA, in 2016, more than 6% of 4 million child births in the U.S. every year needs neonatal intensive care unit (NICU) admission and majority of them were due to preterm birth. NICU is also utilized for newborn babies with health disorders such as heart problems, infections, or birth defects. Increasing population along with increasing hospital admissions in the Asia Pacific is a major factor in escalating the growth in the end user segment. Moreover, growth in the specialty clinics and nursing homes in the emerging nations along with increased government funding for child care has sustained the administrations of neonatal intensive care respiratory devices on a global scale.
"Increasing population, new product launches and the presence of top players holds the U.S. in dominant position"
In 2018, the U.S contributed maximum revenue in the global neonatal intensive care respiratory devices market accredited to the rising prevalence of respiratory disorders. Major factors include increasing awareness, FDA approvals for advanced devices, and increasing emergency care services along with better reimbursement structure. Developing nations always suffer the burden of neonatal and fetal deaths. As per WHO, more than 2.5 million infant deaths were reported in the year 2017. Nevertheless, in poorer nations the accessibility of advanced devices are limited. Lack of skilled physicians, very less suitability of medical treatment and the high cost of various products along with the availability are few factors restraining the overall growth of the neonatal intensive care respiratory devices market.
"Dominance of multinational manufacturers with strong product portfolio in the developed regions"
Major players in the neonatal intensive care respiratory devices market are GE Healthcare, Medtronic plc., C. R. Bard, Inc., Inspiration Healthcare Group plc, Getinge AB, Drägerwerk AG & Co. KGaA, Becton, Dickinson and Company, Cook Medical, Teleflex Incorporated, Trudell Medical International, Mercury Medical and others. Major organizations are executing progressive strategies with new medical technology expansion in neonatal intensive care respiratory devices designs along with acquisitions and partnerships with top medical device manufacturers.
Historical & Forecast Period
This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.
Market Segmentation
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2017-2027 |
| Base Year | 2018 |
| Forecast Period | 2019-2027 |
| Historical Year | 2017 |
| Unit | USD Million |
| Segmentation |
Device Type (2017–2027; US$ Mn) |
|
End User Segment (2017–2027; US$ Mn) |
|
|
Geography Segment (2017–2027; US$ Mn) |
The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall neonatal intensive care respiratory devices market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Key questions answered in this report
- What are the current market trends and dynamics in the neonatal intensive care respiratory devices market and valuable opportunities for emerging players?
- Market positioning of major key players operating in the market?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which device type segment holds a larger market share and why?
- Are low and middle-income economies investing in the neonatal intensive care respiratory devices market?
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global NICRD Market Portraiture
2.2. Global NICRD Market, By Device Type, 2018 (US$ Mn)
2.3. Global NICRD Market, By End User, 2018 (US$ Mn)
2.4. Global NICRD Market, by Geography, 2018 vs. 2027 (Value %)
Chapter 3. Global Neonatal Intensive Care Respiratory Devices (NICRD) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. NICRD Market Technologies: Future Trends
3.3. Current Scenario: New Product Launches, High Prevalence For Cardiovascular Diseases
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2018
Chapter 4. Global Neonatal Intensive Care Respiratory Devices (NICRD) Market, by Device Type, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Nebulizers
4.3. Inhalers
4.4. Ventilators
4.5. Continuous Positive Airway Pressure Devices
4.6. Apnea Monitors
Chapter 5. Global Neonatal Intensive Care Respiratory Devices (NICRD) Market, By End User, 2017 – 2027 (US$)
5.1. Overview
5.2. NICU Hospitals
5.3. Specialty Clinics
5.4. Nursing Homes
Chapter 6. Global Neonatal Intensive Care Respiratory Devices (NICRD) Market, by Geography, 2017 – 2027 (US$ Mn)
6.1. Overview
6.2. North America NICRD Market Analysis, 2017 – 2027
6.2.1. North America NICRD Market, By Device Type, 2017 – 2027 (US$ Mn)
6.2.2. North America NICRD Market, By End User, 2017 – 2027 (US$ Mn)
6.2.3. North America NICRD Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe NICRD Market Analysis, 2017 – 2027
6.3.1. Europe NICRD Market, By Device Type, 2017 – 2027 (US$ Mn)
6.3.2. Europe NICRD Market, By End User, 2017 – 2027 (US$ Mn)
6.3.3. Europe NICRD Market, by Country, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific NICRD Market Analysis, 2017 – 2027
6.4.1. Asia Pacific NICRD Market, By Device Type, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific NICRD Market, By End User, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific NICRD Market, by Country, 2017 – 2027 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America NICRD Market Analysis, 2017 – 2027
6.5.1. Latin America NICRD Market, By Device Type, 2017 – 2027 (US$ Mn)
6.5.2. Latin America NICRD Market, By End User, 2017 – 2027 (US$ Mn)
6.5.3. Latin America NICRD Market, by Country, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) NICRD Market Analysis, 2017 – 2027
6.6.1. MEA NICRD Market, by Device Type, 2017 – 2027 (US$ Mn)
6.6.2. MEA NICRD Market, By End User, 2017 – 2027 (US$ Mn)
6.6.3. MEA NICRD Market, by Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. GE Healthcare
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Medtronic plc
7.3. C. R. Bard, Inc.
7.4. Inspiration Healthcare Group plc
7.5. Getinge AB
7.6. Drägerwerk AG & Co. KGaA
7.7. Becton, Dickinson and Company
7.8. Cook Medical
7.9. Teleflex Incorporated
7.10. Trudell Medical International
7.11. Mercury Medical
* Here we are using NICRD as a short form of Neonatal Intensive Care Respiratory Devices
TABLE 1 : Market Snapshot: Global Neonatal Intensive Care Respiratory Devices (NICRD) Market
TABLE 2 : Global NICRD Market, by Device Type, 2017–2027 (US$ Mn)
TABLE 3 : Global NICRD Market, by End User, 2017–2027 (US$ Mn)
TABLE 4 : Global NICRD Market, by Geography, 2017–2027 (US$ Mn)
TABLE 5 : North America NICRD Market, by Device Type, 2017–2027 (US$ Mn)
TABLE 6 : North America NICRD Market, by End User, 2017–2027 (US$ Mn)
TABLE 7 : North America NICRD Market, by Country, 2017–2027 (US$ Mn)
TABLE 8 : Europe NICRD Market, by Device Type, 2017–2027 (US$ Mn)
TABLE 9 : Europe NICRD Market, by End User, 2017–2027 (US$ Mn)
TABLE 10 : Europe NICRD Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 11 : Latin America NICRD Market, by Device Type, 2017–2027 (US$ Mn)
TABLE 12 : Latin America NICRD Market, by End User, 2017–2027 (US$ Mn)
TABLE 13 : Latin America NICRD Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 14 : Asia Pacific NICRD Market, by Device Type, 2017–2027 (US$ Mn)
TABLE 15 : Asia Pacific NICRD Market, by End User, 2017–2027 (US$ Mn)
TABLE 16 : Asia Pacific NICRD Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 17 : Middle East & Africa NICRD Market, by Device Type, 2017–2027 (US$ Mn)
TABLE 18 : Middle East & Africa NICRD Market, by End User, 2017–2027 (US$ Mn)
TABLE 19 : Middle East & Africa NICRD Market, by Region, 2017–2027 (US$ Mn)
TABLE 20 : GE Healthcare.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 21 : Medtronic plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 22 : C. R. Bard, Inc..: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 23 : Inspiration Healthcare Group plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 24 : Getinge AB: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 : Drägerwerk AG & Co. KGaA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 : Becton Dickinson and Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 : Cook Medical: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 : Teleflex Incorporated: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 : Trudell Medical International: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 : Mercury Medical: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
FIG. 1 : Global Neonatal Intensive Care Respiratory Devices (NICRD) Market: Research Methodology
FIG. 2 : Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 : Global NICRD Market Segmentation
FIG. 4 : Global NICRD Market, by Device Type, 2017 (US$ Mn)
FIG. 5 : Global NICRD Market, by End User, 2017 (US$ Mn)
FIG. 6 : Global NICRD Market, by Geography, 2017 (US$ Mn)
FIG. 7 : Attractive Investment Proposition, by Geography, 2017
FIG. 8 : Global Market Positioning of Key NICRD Market Manufacturers, 2017
FIG. 9 : Global NICRD Market for Nebulizers, 2017–2027 (US$ Mn)
FIG. 10 : Global NICRD Market for Inhalers, 2017–2027 (US$ Mn)
FIG. 11 : Global NICRD Market for Ventilators, 2017–2027 (US$ Mn)
FIG. 12 : Global NICRD Market for Continuous Positive Airway Pressure Devices, 2017–2027 (US$ Mn)
FIG. 13 : Global NICRD Market for Apnea Monitors, 2017–2027 (US$ Mn)
FIG. 14 : Global NICU Hospitals Market (End User), 2017–2027 (US$ Mn)
FIG. 15 : Global Specialty Clinics Market (End User), 2017–2027 (US$ Mn
FIG. 16 : Global Nursing Homes Market (End User), 2017–2027 (US$ Mn
FIG. 17 : U.S. NICRD Market, 2017–2027 (US$ Mn)
FIG. 18 : Canada NICRD Market, 2017–2027 (US$ Mn)
FIG. 19 : U.K. NICRD Market, 2017–2027 (US$ Mn)
FIG. 20 : Germany NICRD Market, 2017–2027 (US$ Mn)
FIG. 21 : Rest of Europe NICRD Market, 2017–2027 (US$ Mn)
FIG. 22 : Japan NICRD Market, 2017–2027 (US$ Mn)
FIG. 23 : China NICRD Market, 2017–2027 (US$ Mn)
FIG. 24 : Rest of Asia Pacific NICRD Market, 2017–2027 (US$ Mn)
FIG. 25 : Brazil NICRD Market, 2017–2027 (US$ Mn)
FIG. 26 : Mexico NICRD Market, 2017–2027 (US$ Mn)
FIG. 27 : Rest of Latin America NICRD Market, 2017–2027 (US$ Mn)
FIG. 28 : GCC NICRD Market, 2017–2027 (US$ Mn)
FIG. 29 : Rest of Middle East & Africa NICRD Market, 2017–2027 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)